Characteristics and outcomes of COVID-19 patients with IPF: A multi-center retrospective study
A Cilli, I Hanta, F Uzer, F Coskun, C Sevinc… - … Medicine and Research, 2022 - Elsevier
Background There are few data on severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2)(COVID-19) infection in patients with idiopathic pulmonary fibrosis (IPF). The …
CoV-2)(COVID-19) infection in patients with idiopathic pulmonary fibrosis (IPF). The …
Pulmonary fibrosis in patients with COVID-19: A retrospective study
F Li, J Deng, Y Song, C Wu, B Yu, G Wang… - Frontiers in Cellular …, 2022 - frontiersin.org
Background Coronavirus disease 2019 (COVID-19) pandemic has caused substantial
threats to people's physical health and lives, claiming the lives of over 6 million people …
threats to people's physical health and lives, claiming the lives of over 6 million people …
Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with …
ZB Harboe, SR Hamm, L Pérez-Alós… - BMJ Open …, 2022 - bmjopenrespres.bmj.com
Introduction Responses to COVID-19 vaccination in patients with chronic pulmonary
diseases are poorly characterised. We aimed to describe humoral responses following two …
diseases are poorly characterised. We aimed to describe humoral responses following two …
[引用][C] Antibody Responses and Risk Factors Associated With Impaired Immunological Outcomes Following Two Doses of BNT162b2 COVID-19 Vaccination in …
Z Barrella Harboe, SR Hamm, L Pérez-Alós…